Ismaheel O Lawal1, Alfred O Ankrah1,2, Gbenga O Popoola3, Thabo Lengana1, Mike M Sathekge4. 1. Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa. 2. Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. 3. Department of Epidemiology and Community Health, University of Ilorin, Ilorin, Nigeria. 4. Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Private Bag X169, Pretoria, 0001, South Africa. mike.sathekge@up.ac.za.
Abstract
BACKGROUND: HIV infection is associated with the risk of development of atherosclerosis at a younger age. We compared arterial inflammation in HIV-infected and HIV-uninfected patients with otherwise low-risk factors for cardiovascular disease (CVD) using FDG PET/CT. METHODS: 242 patients aged 18-40 years with low-risk factors for CVD consisting of 121 HIV-infected patients and 121 HIV-uninfected age- and gender-matched controls were studied, mean age = 34.95 ± 5.46 years. We calculated and compared the target-to-background ratio of FDG uptake in ascending aorta of HIV-infected and non-infected patients. RESULTS: Median CD4 count and viral load were 375.5 cells/mm3 (range 2-1094) and 6391.00 copies/mL (range 24-1,348,622), respectively. There was slightly higher but significant overlap in the TBR between HIV-infected group compared with control (1.22, 0.87-2.02 vs. 1.12, 0.38-1.40, P < 0.001). TBR was neither affected by CD4 count levels nor the presence or absence of detectable viremia. We also found no significant difference in TBR between male and female patients with HIV infection. We found a weak positive correlation between TBR and CD4 count, TBR and duration of HIV infection, and a very weak negative correlation between TBR and viral load. There was no significant difference in TBR between patients on HAART and those not yet commenced on therapy. CONCLUSION: Marginally higher TBR with a significant overlap exist in HIV-infected patients compared with control. Arterial F-18 FDG uptake is not affected by the CD 4 count, viral load, gender, or duration of HIV infection.
BACKGROUND:HIV infection is associated with the risk of development of atherosclerosis at a younger age. We compared arterial inflammation in HIV-infected and HIV-uninfectedpatients with otherwise low-risk factors for cardiovascular disease (CVD) using FDG PET/CT. METHODS: 242 patients aged 18-40 years with low-risk factors for CVD consisting of 121 HIV-infectedpatients and 121 HIV-uninfected age- and gender-matched controls were studied, mean age = 34.95 ± 5.46 years. We calculated and compared the target-to-background ratio of FDG uptake in ascending aorta of HIV-infected and non-infectedpatients. RESULTS: Median CD4 count and viral load were 375.5 cells/mm3 (range 2-1094) and 6391.00 copies/mL (range 24-1,348,622), respectively. There was slightly higher but significant overlap in the TBR between HIV-infected group compared with control (1.22, 0.87-2.02 vs. 1.12, 0.38-1.40, P < 0.001). TBR was neither affected by CD4 count levels nor the presence or absence of detectable viremia. We also found no significant difference in TBR between male and female patients with HIV infection. We found a weak positive correlation between TBR and CD4 count, TBR and duration of HIV infection, and a very weak negative correlation between TBR and viral load. There was no significant difference in TBR between patients on HAART and those not yet commenced on therapy. CONCLUSION: Marginally higher TBR with a significant overlap exist in HIV-infectedpatients compared with control. Arterial F-18 FDG uptake is not affected by the CD 4 count, viral load, gender, or duration of HIV infection.
Authors: Janet Lo; Michael T Lu; Ezinne J Ihenachor; Jeffrey Wei; Sara E Looby; Kathleen V Fitch; Jinhee Oh; Chloe O Zimmerman; Janice Hwang; Suhny Abbara; Jorge Plutzky; Gregory Robbins; Ahmed Tawakol; Udo Hoffmann; Steven K Grinspoon Journal: Lancet HIV Date: 2015-01-09 Impact factor: 12.767
Authors: Ahmed Tawakol; Raymond Q Migrino; Gregory G Bashian; Shahinaz Bedri; David Vermylen; Ricardo C Cury; Denise Yates; Glenn M LaMuraglia; Karen Furie; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman Journal: J Am Coll Cardiol Date: 2006-10-17 Impact factor: 24.094
Authors: Kevin E Yarasheski; Erin Laciny; E Turner Overton; Dominic N Reeds; Michael Harrod; Steven Baldwin; Victor G Dávila-Román Journal: J Inflamm (Lond) Date: 2012-06-22 Impact factor: 6.283
Authors: Andreas Knudsen; Anne Mette Fisker Hag; Annika Loft; Eric von Benzon; Sune H Keller; Holger Jon Møller; Anne-Mette Lebech; Rasmus Sejersten Ripa; Andreas Kjær Journal: J Nucl Cardiol Date: 2014-12-03 Impact factor: 5.952
Authors: Jan Bucerius; Venkatesh Mani; Colin Moncrieff; Josef Machac; Valentin Fuster; Michael E Farkouh; Ahmed Tawakol; James H F Rudd; Zahi A Fayad Journal: Eur J Nucl Med Mol Imaging Date: 2013-11-23 Impact factor: 9.236
Authors: Jonathan A Hudson; Edith D Majonga; Rashida A Ferrand; Pablo Perel; Shirjel R Alam; Anoop S V Shah Journal: JAMA Date: 2022-09-13 Impact factor: 157.335
Authors: Michael H Chung; Anoop Sv Shah; Hassan Adan Ahmed; Jeilan Mohamed; Isaiah G Akuku; Kuan Ken Lee; Shirjel R Alam; Pablo Perel; Jasmit Shah; Mohammed K Ali; Sherry Eskander Journal: BMJ Open Date: 2022-06-06 Impact factor: 3.006
Authors: Ismaheel O Lawal; Kgomotso G Mokoala; Gbenga O Popoola; Thabo Lengana; Alfred O Ankrah; Anton C Stoltz; Mike M Sathekge Journal: J Nucl Cardiol Date: 2019-08-06 Impact factor: 5.952
Authors: Ismaheel O Lawal; Akintunde T Orunmuyi; Gbenga O Popoola; Thabo Lengana; Kgomotso M G Mokoala; Alfred O Ankrah; Mike M Sathekge Journal: Medicine (Baltimore) Date: 2020-11-25 Impact factor: 1.889
Authors: Nevio Taglieri; Rachele Bonfiglioli; Isabella Bon; Pietro Malosso; Andrej Corovic; Matteo Bruno; Elizabeth Le; Bianca Granozzi; Tullio Palmerini; Gabriele Ghetti; Martina Tamburello; Antonio Giulio Bruno; Francesco Saia; Jason M Tarkin; James H F Rudd; Leonardo Calza; Stefano Fanti; Maria Carla Re; Nazzareno Galié Journal: J Nucl Cardiol Date: 2021-02-10 Impact factor: 3.872